For: | Wang Y, Song M, Qi BR. Effects of insulin aspart and metformin on gestational diabetes mellitus and inflammatory markers. World J Diabetes 2023; 14(10): 1532-1540 [PMID: 37970132 DOI: 10.4239/wjd.v14.i10.1532] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v14/i10/1532.htm |
Number | Citing Articles |
1 |
Junfen Cui. Effects of metformin combined with insulin aspart on gestational weight gain, lipid metabolism, immune function, and delivery outcomes in pregnant women with gestational diabetes. American Journal of Translational Research 2025; 17(5): 3435 doi: 10.62347/ROSD8026
|
2 |
Joseph M. Walter, Taylor Parajon, Erin McDonough, Nicolle Dambly, Alayna Sedgwick, Justine Choe. . Side Effects of Drugs Annual 2024; 46: 491 doi: 10.1016/bs.seda.2024.08.001
|
3 |
Xiaojun Fan. Improved pregnancy outcome in gestational diabetes mellitus patients treated with insulin aspart and metformin: a comparative study. American Journal of Translational Research 2024; 16(4): 1177 doi: 10.62347/NIGM4906
|
4 |
Peishan LI, Yunyun Liu, Juan Liao, Mingli Rao, Ling Peng, Ya Wang, Lin Shang, Xue Liu, Zhenghua Xiao. FSP1 and CoQ10 have the potential to serve as biomarkers for severe preeclampsia. BMC Pregnancy and Childbirth 2025; 25(1) doi: 10.1186/s12884-025-07930-4
|
5 |
Bin Chen, Yanghao Tai, Yingming Kong, Chunyan Wang. Association between metformin use and reduced short- and long-term all-cause mortality in patients undergoing cardiac surgery: a retrospective cohort study. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-02878-9
|
6 |
Huiying Qiu. Insulin aspart plus high-dose vitamin D supplementation for gestational diabetes mellitus: analysis of efficacy and risk factors for maternal and infant outcomes. American Journal of Translational Research 2024; 16(8): 4200 doi: 10.62347/PKAY4284
|